THERESE BARTHOLOMEW BEVERS's research topics

THERESE BARTHOLOMEW BEVERS

Concepts (337)

Back to Profile

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with THERESE BARTHOLOMEW BEVERS's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that THERESE BARTHOLOMEW BEVERS has written about over time.

Raloxifene Hydrochloride, 8 publications between 2001 and 2015, average publication date July 2008. Tamoxifen, 12 publications between 2000 and 2022, average publication date July 2009. Breast Self-Examination, 2 publications between 2009 and 2012, average publication date April 2011. Selective Estrogen Receptor Modulators, 10 publications between 2006 and 2018, average publication date October 2012. Risk Reduction Behavior, 5 publications between 2008 and 2017, average publication date June 2013. Breast Neoplasms, 65 publications between 2000 and 2024, average publication date June 2014. Uterine Cervical Dysplasia, 4 publications between 2007 and 2023, average publication date June 2015. Mass Screening, 12 publications between 2006 and 2024, average publication date January 2016. Decision Making, 7 publications between 2010 and 2018, average publication date July 2016. Precancerous Conditions, 4 publications between 2012 and 2023, average publication date October 2016. Mammography, 18 publications between 2006 and 2024, average publication date March 2017. Aromatase Inhibitors, 4 publications between 2015 and 2022, average publication date October 2017. Early Detection of Cancer, 17 publications between 2012 and 2023, average publication date January 2018. Breast, 8 publications between 2012 and 2021, average publication date March 2018. Hyperplasia, 7 publications between 2014 and 2023, average publication date May 2018. Carcinoma, Lobular, 5 publications between 2014 and 2023, average publication date September 2018. Patient Participation, 6 publications between 2017 and 2020, average publication date October 2018. Breast Carcinoma In Situ, 2 publications between 2018 and 2020, average publication date May 2019. Smokers, 1 publications between 2020 and 2020, average publication date January 2020. Medical Oncology, 3 publications between 2018 and 2023, average publication date June 2020.

Raloxifene Hydrochloride
Tamoxifen
Breast Self-Examination
Selective Estrogen Receptor Modulators
Risk Reduction Behavior
Breast Neoplasms
Uterine Cervical Dysplasia
Mass Screening
Decision Making
Precancerous Conditions
Mammography
Aromatase Inhibitors
Early Detection of Cancer
Breast
Hyperplasia
Carcinoma, Lobular
Patient Participation
Breast Carcinoma In Situ
Smokers
Medical Oncology

To see the data from this visualization as text, click here.

Name	Number of Publications	First Publication Year	Most Recent Publication Year	Average Publication Date
Raloxifene Hydrochloride	8	2001	2015	July 2008
Tamoxifen	12	2000	2022	July 2009
Breast Self-Examination	2	2009	2012	April 2011
Selective Estrogen Receptor Modulators	10	2006	2018	October 2012
Risk Reduction Behavior	5	2008	2017	June 2013
Breast Neoplasms	65	2000	2024	June 2014
Uterine Cervical Dysplasia	4	2007	2023	June 2015
Mass Screening	12	2006	2024	January 2016
Decision Making	7	2010	2018	July 2016
Precancerous Conditions	4	2012	2023	October 2016
Mammography	18	2006	2024	March 2017
Aromatase Inhibitors	4	2015	2022	October 2017
Early Detection of Cancer	17	2012	2023	January 2018
Breast	8	2012	2021	March 2018
Hyperplasia	7	2014	2023	May 2018
Carcinoma, Lobular	5	2014	2023	September 2018
Patient Participation	6	2017	2020	October 2018
Breast Carcinoma In Situ	2	2018	2020	May 2019
Smokers	1	2020	2020	January 2020
Medical Oncology	3	2018	2023	June 2020

BEVERS's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (337)

Explore

Co-Authors (87)

Explore

Similar People (60)

Explore

Same Department

Explore